These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27575527)

  • 1. [Clinical consequences of using the new cardiovascular risk tables SCORE OP in patients aged over 65 years].
    Brotons C; Moral I; Fernández D; Cuixart L; Muñoz A; Soteras A; Puig M; Joaniquet X; Casasa A
    Med Clin (Barc); 2016 Nov; 147(9):381-386. PubMed ID: 27575527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of using different SCORE tables for estimating cardiovascular risk.
    Brotons C; Moral I; Soriano N; Cuixart L; Osorio D; Bottaro D; Puig M; Joaniquet X; Marcos A; Casasa A
    Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):94-100. PubMed ID: 24795115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk assessment in elderly adults using SCORE OP model in a Latin American population: The experience from Ecuador.
    Sisa I
    Med Clin (Barc); 2018 Feb; 150(3):92-98. PubMed ID: 29033193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of repeat serum cholesterol measurements for assessment of cardiovascular risk in primary prevention.
    Angelow A; Schmidt CO; Dörr M; Chenot JF
    Eur J Prev Cardiol; 2016 Apr; 23(6):628-35. PubMed ID: 26170419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Limitations of the utilization of cardiovascular risk tables and statins].
    Palomo L; Sánchez-Robles G
    Med Clin (Barc); 2015 Apr; 144(7):334-5. PubMed ID: 25015254
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal.
    Piccininni M; Rohmann JL; Huscher D; Mielke N; Ebert N; Logroscino G; Schäffner E; Kurth T
    PLoS One; 2020; 15(4):e0231097. PubMed ID: 32271825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cardiovascular risk in primary care patients in France.
    Bruckert E; Bonnelye G; Thomas-Delecourt F; André L; Delaage PH
    Arch Cardiovasc Dis; 2011; 104(6-7):381-7. PubMed ID: 21798470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Appropriateness of lipid-lowering treatment and cardiovascular risk in patients with hypercholesterolemia].
    Segade Buceta XM; Dosil Díaz O
    Gac Sanit; 2002; 16(4):318-23. PubMed ID: 12106551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the new American and British guidelines on the management and treatment of dyslipidemia in a Spanish working population.
    Brotons C; Calvo-Bonacho E; Moral I; García-Margallo MT; Cortés-Arcas MV; Puig M; Vázquez-Pirillo G; Ruilope LM
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):906-11. PubMed ID: 25278212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
    Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
    Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.
    Ara R; Pandor A; Tumur I; Paisley S; Duenas A; Williams R; Wilkinson A; Durrington P; Chilcott J
    Clin Ther; 2008 Aug; 30(8):1508-23. PubMed ID: 18803993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.
    Ko DT; Mamdani M; Alter DA
    JAMA; 2004 Apr; 291(15):1864-70. PubMed ID: 15100205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
    Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
    Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.